We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Survey Assesses Patients’ Understanding of Own Imaging Exams

By MedImaging International staff writers
Posted on 12 May 2015
A study by researchers at the NYU Langone Medical Center (New York, NY, USA) investigating patients’ knowledge of the nature of imaging exams they were about to undergo, has been published online in the April 10, 2015, issue of the Journal of the American College of Radiology.

A total of 176 patients, 109 women and 67 men, with a mean age of 50 years, completed a survey, before undergoing a radiological imaging examination at NYU Langone Medical Center. Forty-one of the patients were waiting for Magnetic Resonance Imaging (MRI), 44 for nuclear medicine, and 45 for Computed Tomography (CT) exams.

The results showed that only 76 of 166 knew if their examination would involve the use ionizing radiation, and 23 of 45 knew that intravenous contrast was going to be injected for their examination. Most patients said that the ordering physician had explained the examination beforehand. A significant number, 90 of 170 patients, wanted to discuss the examination with a radiologist beforehand.

Patients coming for a CT were most informed about their exam, while those coming for nuclear medicine were least informed.

The study concluded that the patients were only partially knowledgeable about their upcoming imaging examinations, and that initiatives to improve patients’ empowerment, and understanding were necessary to improve patient-centered care.

Related Links:

NYU Langone Medical Center 


Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
MRI System
nanoScan MRI 3T/7T
Portable X-ray Unit
AJEX140H
High-Precision QA Tool
DEXA Phantom

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.